<DOC>
	<DOCNO>NCT01532154</DOCNO>
	<brief_summary>This global pregnancy registry evaluate outcome pregnancy woman multiple sclerosis expose prolonged-release fampridine since first day last menstrual period prior conception time pregnancy .</brief_summary>
	<brief_title>Fampridine Pregnancy Exposure Registry</brief_title>
	<detailed_description>There mandatory physician visit . The registry collect pregnancy outcome data participant health care provider prenatal follow ( 6-7 month gestation ) , pregnancy outcome ( 4 week estimate delivery date ) finally pediatric follow ( 4 week 12 week post birth ) .</detailed_description>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>4-Aminopyridine</mesh_term>
	<criteria>Key Documentation patient expose prolongedrelease fampridine since first day last menstrual period ( LMP ) prior conception time pregnancy . ( If exposure date unknown , reporter must able specify estimate trimester exposure . ) The outcome pregnancy must know time report . Key NOTE : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>